Structure.jpg (Structure)
Fingolimod Capsule
Product Images NDC 68462-166
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Fingolimod (NDC 68462-166). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Blistercarton7cap (Blistercarton7cap)
Fingolimod Capsules are a medication containing 0.5 mg fingolimod. The package contains a one-week supply of capsules and comes with an enclosed medication guide. The capsules can be accessed by following the opening instructions: press and hold the "PRESS AND HOLD HERE" button gently, then pull the "PULL OUT HERE" tab. To release the capsule, press on the capsule and push through the paper backing. This package is child-resistant and should be stored at 20°C to 25°C. It is manufactured for Glenmark Pharmaceuticals Inc. in the USA and is a product of India. Usual Dosage: See package insert.*
Bottlelabel (Bottlelabel)
Figure1 (Figure1)
Glenmarklogo (Glenmarklogo)
Logo (Logo)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
